Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Lenvatinib in Patients With Advanced Parathyroid Carcinoma(ALPS)

NCT07843901 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT07843901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07843901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Lenvatinib in Patients With Advanced Parathyroid Carcinoma(ALPS)
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
August 31, 2029
Enrollment
18 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

parathyroid carcinoma